Efficacy and safety of targeted therapy for metastatic HER2-positive breast cancer in the first-line treatment: a Bayesian network meta-analysis

Efficacy and safety of targeted therapy for metastatic HER2-positive breast cancer in the first-line treatment: a Bayesian network meta-analysis

Fubin Feng,1 Tingting Zhang,2 Fang Yin,3 Cun Liu,2 Jing Zhuang,1 Lingyu Qi,2 Xue Wang,4 Jia Li,5 Lu Wang,1 Jinhui Tian,6 Changgang Sun1,7 1Department of Oncology, Weifang Traditional Chinese Hospital, Weifang, Shandong Province, China; 2College of Traditional Chinese Medicine, Shandong University o...

Full description

Bibliographic Details
Main Authors: Feng F, Zhang T, Yin F, Liu C, Zhuang J, Qi L, Wang X, Li J, Wang L, Tian J, Sun C
Format: Article
Language:English
Published: Dove Medical Press 2019-01-01
Series:OncoTargets and Therapy
Subjects:
breast cancer
metastasis
HER2-positive
HER2-targeted agents
network meta-analysis
randomized controlled trial
Online Access:https://www.dovepress.com/efficacy-and-safety-of-targeted-therapy-for-metastatic-her2-positive-b-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/efficacy-and-safety-of-targeted-therapy-for-metastatic-her2-positive-b-peer-reviewed-article-OTT

Similar Items